A young man who was once athletic and full of life died on his 22nd birthday after a devastating illness linked to COVID-19 left him bedridden, unable to tolerate light or sound, and struggling to communicate even with his own mother.
Samuel Prinz-Reiterer, from Austria, died through legally assisted suicide on January 30, 2026, after his health deteriorated dramatically following a coronavirus infection in the summer of 2024.
Just 12 days before his death, Samuel shared a heartbreaking public message describing his suffering and pleading for greater awareness of a debilitating condition that he believed was being neglected by the medical system.
His story, which has resurfaced in international headlines this November, is now raising difficult questions about the treatment of people with severe chronic illnesses and the controversial laws allowing assisted dying.
Samuel suffered from myalgic encephalomyelitis/chronic fatigue syndrome, commonly known as ME/CFS, a serious neurological and multisystem illness that can develop following viral infections.
Despite its name, the condition involves far more than ordinary exhaustion. Patients can experience overwhelming fatigue, severe pain, cognitive difficulties and a worsening of symptoms after even minimal physical or mental activity.
For Samuel, the disease became so severe that everyday activities were nearly impossible.
He spent virtually all his time confined to a darkened bedroom, wearing hearing protection because ordinary sounds had become unbearable. Watching television, listening to music and even holding conversations could trigger debilitating symptoms.
Eventually, he could communicate with his mother, who cared for him, only through written messages.
His neurologist, Dr. Andreas Winkler, confirmed that Samuel’s condition had progressively worsened despite medical efforts to help him.
Winkler told Austrian newspaper Der Standard that Samuel had initially been able to walk around his parents’ apartment and occasionally venture outside. Over time, however, his symptoms became so severe that he could no longer leave his bed.
The young man went public with his condition on January 18, explaining that he had decided to pursue assisted dying under Austrian law.
But Samuel wanted his story to draw attention to something larger than his personal suffering.
He criticized the lack of specialized medical services, financial assistance and recognition available to people living with ME/CFS, an illness that remains poorly understood despite affecting millions worldwide.
His physician echoed those concerns, describing serious gaps in Austria’s healthcare system and a shortage of doctors experienced in treating the condition.
The tragedy also highlights a growing issue in the United States.
According to the Centers for Disease Control and Prevention, as many as 3.3 million Americans may have ME/CFS, with most cases going undiagnosed.
There is currently no known cure, although medical care can help patients manage individual symptoms. Researchers are continuing to investigate the illness, particularly its relationship to long COVID.
Samuel’s death has also renewed attention on Austria’s assisted-dying legislation.
The country legalized assisted suicide under specific conditions in January 2022, allowing qualifying adults with terminal illnesses or severe, permanent medical conditions to make the decision following medical assessments and other legal safeguards.
The practice has increased substantially since the law took effect.
New government figures show that 198 people died through assisted suicide in Austria in 2025, compared with 54 in 2022, an increase of approximately 267 percent.
The figures have prompted renewed debate over whether existing safeguards are adequate and whether seriously ill people receive sufficient medical, psychological and financial support.
The British advocacy organization Right To Life has called for an independent investigation into the country’s assisted-dying system, arguing that vulnerable patients must have meaningful access to care and alternatives.
Supporters of assisted-dying laws, meanwhile, emphasize the importance of personal autonomy and allowing qualifying patients to make deeply private medical decisions under strict safeguards.
The debate remains particularly sensitive in cases involving younger people with serious but nonterminal illnesses.
For Samuel’s family, however, the focus has remained on ensuring that greater awareness and research emerge from his death.
At his funeral on February 11, relatives asked mourners to donate to ME/CFS research rather than purchase flowers.
The request raised approximately 5,000 euros, which the family directed to the Austrian Society for ME/CFS.
His mother later remembered him as someone who had been cheerful and enthusiastic about life before his illness.
Samuel’s story has become a painful reminder of how dramatically a serious post-viral illness can change a person’s life, sometimes leaving patients and their families struggling to find adequate medical support.
And beyond the international debate over assisted dying, his family’s efforts have placed another urgent question at the center of the conversation: What more can healthcare systems do to ensure that people living with devastating chronic illnesses receive the treatment, research and support they desperately need?
Discover more from Next Gen News
Subscribe to get the latest posts sent to your email.

